Skip to main content

Table 4 Hazard ratios and 95% confidence intervals of myocardial infarction and stroke by low-density lipoprotein cholesterol (LDL-C) category; Sensitivity analysis excluding subjects with the occurrence of end points within 2 year of follow-up

From: Cholesterol levels and development of cardiovascular disease in Koreans with type 2 diabetes mellitus and without pre-existing cardiovascular disease

 

Total

Statin non-user

Statin user

Events (n)

Incidence rate (per 1000 person-years)

HR (95% CI)*

Events (n)

Incidence rate (per 1000 person-years)

HR (95% CI)*

Events (n)

Incidence rate (per 1000 person-years)

HR (95% CI)*

MI

 < 70

4058

3.78

1 (ref.)

1788

3.77

1 (ref.)

2270

3.79

1 (ref.)

 70–99

9274

3.65

1.00 (0.96, 1.03)

5467

3.49

0.94 (0.90, 1.00)

3807

3.90

1.05 (1.00, 1.11)

 100–129

11,518

3.74

1.07 (1.03, 1.11)

8591

3.62

1.02 (0.97, 1.07)

2927

4.12

1.15 (1.09, 1.21)

 130–159

8182

4.10

1.22 (1.18, 1.27)

6209

4.06

1.20 (1.13, 1.26)

1973

4.20

1.21 (1.14, 1.29)

 ≥ 160

4887

4.63

1.44 (1.38, 1.50)

3148

4.80

1.48 (1.40, 1.57)

1739

4.36

1.32 (1.24, 1.41)

P for trend

  

< 0.0001

  

< 0.0001

  

< 0.0001

Stroke

 < 70

6434

6.03

1 (ref.)

3083

6.54

1 (ref.)

3351

5.62

1 (ref.)

 70–99

14,892

5.89

1.00 (0.97, 1.03)

9410

6.04

0.96 (0.92, 1.01)

5482

5.64

1.03 (0.99, 1.08)

 100–129

18,137

5.91

1.04 (1.01, 1.07)

14,011

5.94

0.99 (0.95, 1.03)

4126

5.83

1.11 (1.06, 1.16)

 130–159

11,707

5.89

1.08 (1.05, 1.12)

9052

5.95

1.05 (1.01, 1.09)

2655

5.68

1.12 (1.07, 1.18)

 ≥ 160

6280

5.97

1.17 (1.13, 1.21)

4070

6.22

1.15 (1.09, 1.20)

2210

5.56

1.16 (1.11, 1.23)

P for trend

  

< 0.0001

  

< 0.0001

  

< 0.0001

  1. HR, hazard ratio; CI, confidence interval
  2. * Adjusted for age, sex, BMI, smoking, alcohol drinking, exercise, income status, use of statins, fasting glucose levels, hypertension, and duration of diabetes